Deregulated JAK/STAT signaling due to JAK1 and JAK3 somatic mutations has also been observed in Cutaneous T-Cell Lymphoma (CTCL), supporting malignant proliferation (190). The gene discussed is JAK3; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.